A tradução ainda não está pronta. Exibimos o artigo original.
Prediction market event contracts on both clinical drug trials and Food and Drug Administration regulatory approvals are drawing attention from two Democratic senators, according to a letter obtained first by CNBC. Sen. Angela Alsobrooks , D-Md., and Sen. Ron Wyden , D-Ore., expressed concern over the related event contracts in a Wednesday letter to Department of Health and Human Services Secretary Robert F. Kennedy Jr . The senators asked what measures HHS has taken to mitigate any risks that may arise from the markets.
Mostramos publicamente o ponto principal. Crie uma conta gratuita para continuar lendo o artigo completo, salva-lo, comenta-lo e conecta-lo ao contexto de mercado e OSINT.